Kagamu H - Search Results

1

Author Correction: A retrospective analysis of tumor infiltrating lymphocytes in head and neck squamous cell carcinoma patients treated with nivolumab.

Kuba K, Inoue H, Matsumura S, Enoki Y, Kogashiwa Y, Ebihara Y, Nakahira M, Yamazaki T, Yasuda M, Kaira K, Kagamu H, Sugasawa M. Kuba K, et al. Among authors: kagamu h. Sci Rep. 2023 Jan 26;13(1):1472. doi: 10.1038/s41598-023-28598-w. Sci Rep. 2023. PMID: 36702866 Free PMC article. No abstract available.

2

Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells.

Tanaka H, Yoshizawa H, Yamaguchi Y, Ito K, Kagamu H, Suzuki E, Gejyo F, Hamada H, Arakawa M. Tanaka H, et al. Among authors: kagamu h. J Immunol. 1999 Mar 15;162(6):3574-82. J Immunol. 1999. PMID: 10092816

3

Anti-interferon-gamma autoantibody in a patient with disseminated Mycobacterium avium complex.

Koya T, Tsubata C, Kagamu H, Koyama K, Hayashi M, Kuwabara K, Itoh T, Tanabe Y, Takada T, Gejyo F. Koya T, et al. Among authors: kagamu h. J Infect Chemother. 2009 Apr;15(2):118-22. doi: 10.1007/s10156-008-0662-8. Epub 2009 Apr 25. J Infect Chemother. 2009. PMID: 19396523

4

[Management of bone metastasis originating from lung cancer].

Miura S, Kagamu H, Saijyo Y. Miura S, et al. Among authors: kagamu h. Gan To Kagaku Ryoho. 2012 Aug;39(8):1183-6. Gan To Kagaku Ryoho. 2012. PMID: 22902441 Japanese.

5

Analysis of the influenza A (H1N1) 2009 pandemic infection in Japanese asthmatic patients: using a questionnaire-based survey.

Koshio N, Hasegawa T, Suzuki K, Tanabe Y, Koya T, Sakagami T, Aoki N, Hoshino Y, Kagamu H, Tsukada H, Arakawa M, Gejyo F, Narita I, Suzuki E; Niigata Asthma Treatment Study Group. Koshio N, et al. Among authors: kagamu h. Allergol Int. 2014 Mar;63(1):67-74. doi: 10.2332/allergolint.13-OA-0609. Allergol Int. 2014. PMID: 24457814 Free article.

6

Development of a video image-based QA system for the positional accuracy of dynamic tumor tracking irradiation in the Vero4DRT system.

Ebe K, Sugimoto S, Utsunomiya S, Kagamu H, Aoyama H, Court L, Tokuyama K, Baba R, Ogihara Y, Ichikawa K, Toyama J. Ebe K, et al. Among authors: kagamu h. Med Phys. 2015 Aug;42(8):4745-54. doi: 10.1118/1.4926779. Med Phys. 2015. PMID: 26233202

7

Reciprocal CD4+ T-cell balance of effector CD62Llow CD4+ and CD62LhighCD25+ CD4+ regulatory T cells in small cell lung cancer reflects disease stage.

Koyama K, Kagamu H, Miura S, Hiura T, Miyabayashi T, Itoh R, Kuriyama H, Tanaka H, Tanaka J, Yoshizawa H, Nakata K, Gejyo F. Koyama K, et al. Among authors: kagamu h. Clin Cancer Res. 2008 Nov 1;14(21):6770-9. doi: 10.1158/1078-0432.CCR-08-1156. Clin Cancer Res. 2008. PMID: 18980970

8

Critical role of CD11a (LFA-1) in therapeutic efficacy of systemically transferred antitumor effector T cells.

Mukai S, Kagamu H, Shu S, Plautz GE. Mukai S, et al. Among authors: kagamu h. Cell Immunol. 1999 Mar 15;192(2):122-32. doi: 10.1006/cimm.1998.1439. Cell Immunol. 1999. PMID: 10087180

9

Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression.

Hiura T, Kagamu H, Miura S, Ishida A, Tanaka H, Tanaka J, Gejyo F, Yoshizawa H. Hiura T, et al. Among authors: kagamu h. J Immunol. 2005 Oct 15;175(8):5058-66. doi: 10.4049/jimmunol.175.8.5058. J Immunol. 2005. PMID: 16210609

10

[Management of adverse effects of standard regimens for small cell lung cancer].

Kagamu H, Saijo Y. Kagamu H, et al. Nihon Rinsho. 2015 Feb;73 Suppl 2:537-41. Nihon Rinsho. 2015. PMID: 25831818 Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters